(Q34327340)

English

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma

scientific article

Statements

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma (English)
Vanna Chiarion-Sileni
Philip Friedlander

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit